Pathology and clinical features of angioimmunoblastic T-cell lymphoma after successful treatment with thalidomide

被引:35
作者
Dogan, A
Ngu, LSP
Ng, SH
Cervi, PL
机构
[1] Mayo Clin & Mayo Fdn, Dept Lab Med & Pathol, Rochester, MN 55905 USA
[2] Basildon & Thurrock Univ Hosp NHS Trust, Basildon, England
关键词
D O I
10.1038/sj.leu.2403710
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:873 / 875
页数:4
相关论文
共 12 条
[1]   Treatment of angioimmunoblastic T-cell lymphoma with cyclosporine [J].
Advani, R ;
Warnke, R ;
Sikic, BI ;
Horning, S .
ANNALS OF ONCOLOGY, 1997, 8 (06) :601-603
[2]   Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10 [J].
Attygalle, A ;
Al-Jehani, R ;
Diss, TC ;
Munson, P ;
Liu, HX ;
Du, MQ ;
Isaacson, PG ;
Dogan, A .
BLOOD, 2002, 99 (02) :627-633
[3]   Angioimmunoblastic T-cell lymphoma [J].
Dogan, A ;
Attygalle, AD ;
Kyriakou, C .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 121 (05) :681-691
[4]   Thalidomide [J].
Franks, ME ;
Macpherson, GR ;
Figg, WD .
LANCET, 2004, 363 (9423) :1802-1811
[5]  
MURAYAMA T, 1992, CANCER, V69, P2567, DOI 10.1002/1097-0142(19920515)69:10<2567::AID-CNCR2820691029>3.0.CO
[6]  
2-M
[7]   Angioimmunoblastic-like T-cell non Hodgkin's lymphoma: Outcome after chemotherapy in 33 patients and review of the literature [J].
Pautier, P ;
Devidas, A ;
Delmer, A ;
Dombret, H ;
Sutton, L ;
Zini, JM ;
Nedelec, G ;
Molina, T ;
Marolleau, JP ;
Brice, P .
LEUKEMIA & LYMPHOMA, 1999, 32 (5-6) :545-552
[8]   TREATMENT OF ANGIOIMMUNOBLASTIC LYMPHADENOPATHY (AILD)-TYPE T-CELL LYMPHOMA USING PREDNISONE WITH OR WITHOUT THE COPBLAM/IMVP-16 REGIMEN - A MULTICENTER STUDY [J].
SIEGERT, W ;
AGTHE, A ;
GRIESSER, H ;
SCHWERDTFEGER, R ;
BRITTINGER, G ;
ENGELHARD, M ;
KUSE, R ;
TIEMANN, M ;
LENNERT, K ;
HUHN, D .
ANNALS OF INTERNAL MEDICINE, 1992, 117 (05) :364-370
[9]   ANGIOIMMUNOBLASTIC LYMPHADENOPATHY (AILD)-TYPE T-CELL LYMPHOMA - PROGNOSTIC IMPACT OF CLINICAL OBSERVATIONS AND LABORATORY FINDINGS AT PRESENTATION [J].
SIEGERT, W ;
NERL, C ;
AGTHE, A ;
ENGELHARD, M ;
BRITTINGER, G ;
TIEMANN, M ;
LENNERT, K ;
HUHN, D .
ANNALS OF ONCOLOGY, 1995, 6 (07) :659-664
[10]   Antitumor activity of thalidomide in refractory multiple myeloma. [J].
Singhal, S ;
Mehta, J ;
Desikan, R ;
Ayers, D ;
Roberson, P ;
Eddlemon, P ;
Munshi, N ;
Anaissie, E ;
Wilson, C ;
Dhodapkar, M ;
Zeldis, J ;
Barlogie, B ;
Siegel, D ;
Crowley, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (21) :1565-1571